![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessHSPA8 acts as an amyloidase to suppress necroptosis by inhibiting and reversing functional amyloid formation
Ultra-stable fibrous structure is a hallmark of amyloids. In contrast to canonical disease-related amyloids, emerging research indicates that a significant number of cellular amyloids, termed ‘functional amylo...
-
Article
Open AccessThe unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands
Muscarinic acetylcholine receptors (mAChRs) respond to the neurotransmitter acetylcholine and play important roles in human nervous system. Muscarinic receptor 4 (M4R) is a promising drug target for treating n...
-
Article
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties
Partial agonist activity at the dopamine D2 receptor (DRD2) is a key feature of third-generation antipsychotics (TGAs). However, TGAs also act as antagonists or weak partial agonists to the serotonin (5-hydroxytr...
-
Article
Open AccessHaloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
The D2 dopamine receptor (DRD2) is one of the most well-established therapeutic targets for neuropsychiatric and endocrine disorders. Most clinically approved and investigational drugs that target this receptor a...